Collaborating Authors

For a dollar, an AI will examine your medical scan


Engadget met Zebra-Med CEO and co-founder Elad Benjamin at the Hello Tomorrow startup conference in Paris, where he delivered the news about the scans. "We have a product that automatically reads and analyzes medical imaging data from CTs, X-rays, etc.," he said. "And AI1 provides an entire suite [of services] at a flat dollar scale."

Medical cannabis vendors must stop making bogus health claims

New Scientist

Cannabis can make scars disappear, reverse Alzheimer's disease and even cure cancer – that is, if you believe some of the wilder health claims made by US firms in states where medical marijuana has been legalised. Unfortunately, such assertions aren't based on a shred of good evidence. Not only are consumers being ripped off, but sometimes their health is being endangered. Little wonder that the US cannabis industry is sometimes dubbed a Wild-West operation.

Georgia Lawmakers Ready to Expand Access to Medical Cannabis

U.S. News

Georgia Sen. Ben Watson, R - Savannah, left and Rep. Allen Peake, R - Macon, speak during a press conference on a bill opening a popular medical marijuana program to more patients at the Capitol in Atlanta, Tuesday, March 28, 2017. The House approved a bill Tuesday that would add six new diagnoses to the list of qualifying conditions for medical cannabis oil, including autism, AIDS, Tourette's syndrome, and Alzheimer's disease. The bill will have to pass the Senate before moving to the governor who has signaled his approval of the limited program expansion.

Medical School Seeks Subjects for Alzheimer's Study

U.S. News

Murman says he's looking for adults between the ages of 60 and 75 who are at increased risk of developing Alzheimer's symptoms because of a genetic subtype. The trial involves medication designed to decrease a protein called beta amyloid in the brain, which is thought to be an important cause of the disease.

Man Looking at $12 Million Payback in Medical Fraud Case

U.S. News

KOTA-TV reports that Larry Lytle was sentenced in April to 12 years in prison after he was accused of selling hand-held devices to more than 3,000 customers who fell for bogus claims about their effectiveness. Lytle and others claimed the devices could treat more than 200 medical conditions, including diabetes, Alzheimer's disease and AIDS.